Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation (Q45835): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-KA87.2
@@ Property / Canary Token: dki-india-KA87.2 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+P59.3
@@ Property / Linked ICD 10: P59.3 / rank @@
+Normal rank

Latest revision as of 14:04, 13 August 2026

A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother.

Language	Label	Description	Also known as
default for all languages	KA87.2
English	Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation	A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother.